收藏切换
Effect of dapagliflozin in adjuvant treatment of early diabetes nephropathy and its influence on blood glucose and insulin resistance
收藏切换
Yingying ZHANG1, Dongliang GUO1, Shuai HUANG2, *
World Clinical Drug | 2026, 47(1) : 59 - 64
Less
收藏切换
World Clinical Drug | 2026, 47(1): 59-64
• Article •
Effect of dapagliflozin in adjuvant treatment of early diabetes nephropathy and its influence on blood glucose and insulin resistance
Full
Yingying ZHANG1, Dongliang GUO1, Shuai HUANG2, *
Affiliations
  • 1.Department of Endocrinology, Linquan County People's Hospital, Linquan 236400, Anhui Province, China
  • 2.Department of Endocrinology, the Second People's Hospital of Fuyang City, Fuyang 236000, Anhui Province, China
Published: 2026-01-10 doi: 10.13683/j.wph.2026.01.009
Outline
收藏切换

To investigate the efficacy of dapagliflozin as an adjunctive therapy in early-stage diabetic nephropathy(DN) and its impact on blood glucose, insulin resistance(IR), and stress response.

Methods

Patients with early-stage DN admitted to endocrinology department of Linquan county people's hospital from February 2022 to February 2025 were selected as study subjects and randomly divided into the observation group and the control group, with 60 cases in each group. The control group was treated with metformin combined with valsartan, while the observation group additionally received dapagliflozin. The treatment course lasted 3 months. The efficacy, blood glucose levels, IR, stress response, renal function, and safety were compared between the two groups after 1 month and 3 months of treatment.

Results

After 1 month of treatment, there were no significant differences in the levels of 24-hour urine protein(24hUP), serum creatinine(Scr), and estimated glomerular filtration rate(eGFR) between the two groups(P>0.05). After 3 months of treatment, the total effective rate of the observation group was higher than that of the control group(90.00% vs. 75.00%, P<0.05). The eGFR levels of both groups increased compared with those before treatment(P<0.05), and the observation group was higher than that in the control group(P<0.05). Both 24hUP and Scr levels decreased compared with those before treatment(P<0.05), and the observation group was lower than that in the control group(P<0.05). Fasting blood glucose, glycated hemoglobin, 2-hour postprandial blood glucose, and IR index levels assessed by homeostasis model in the observation group were lower than those in the control group(P<0.05).Tumor necrosis factor-α and interleukin-6 in both groups were decreased than those before treatment(P<0.05), and the observation group was lower than the control group(P<0.05). There was no significant difference in complication incidence between the two groups(P>0.05).

Conclusion

Dapagliflozin demonstrates significant efficacy as an adjunctive therapy for early-stage DN, effectively improving blood glucose levels, alleviating IR, and reducing inflammatory responses.

dapagliflozin  /  early-stage diabetic nephropathy  /  blood glucose  /  insulin resistance  /  inflammatory factor
张莹莹, 郭东亮, 黄帅. 达格列净辅助治疗糖尿病肾病早期效果及对血糖、胰岛素抵抗的影响. 世界临床药物, 2026 , 47 (1) : 59 -64 . DOI: 10.13683/j.wph.2026.01.009
Yingying ZHANG, Dongliang GUO, Shuai HUANG. Effect of dapagliflozin in adjuvant treatment of early diabetes nephropathy and its influence on blood glucose and insulin resistance[J]. World Clinical Drug, 2026 , 47 (1) : 59 -64 . DOI: 10.13683/j.wph.2026.01.009
Year 2026 volume 47 Issue 1
48
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.01.009
  • Receive Date:2025-04-28
  • Online Date:2026-11-05
  • Published:2026-01-10
Article Data
Affiliations
History
  • Received:2025-04-28
  • Revised:2025-11-12
Affiliations
    1.Department of Endocrinology, Linquan County People's Hospital, Linquan 236400, Anhui Province, China
    2.Department of Endocrinology, the Second People's Hospital of Fuyang City, Fuyang 236000, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.01.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT